|
Clinical Trials and Observations
Citations 1-10 of 2413 total displayed.
|
Most recent content
(1 Sep 2008):
|
Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature
- Andreas A. Argyriou, Gregoris Iconomou, and Haralabos P. Kalofonos
Blood 2008; 112: 1593-1599.
[Abstract]
[Full text]
[PDF]
European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas
- Nancy J. Senff, Evert M. Noordijk, Youn H. Kim, Martine Bagot, Emilio Berti, Lorenzo Cerroni, Reinhard Dummer, Madeleine Duvic, Richard T. Hoppe, Nicola Pimpinelli, Steven T. Rosen, Maarten H. Vermeer, Sean Whittaker, and Rein Willemze
Blood 2008; 112: 1600-1609.
[Abstract]
[Full text]
[PDF]
The natural history and treatment outcome of blast phase BCR-ABL– myeloproliferative neoplasms
- Constantine S. Tam, Roberto M. Nussenzveig, Uday Popat, Carlos E. Bueso-Ramos, Deborah A. Thomas, Jorge A. Cortes, Richard E. Champlin, Stefan E. Ciurea, Taghi Manshouri, Sherry M. Pierce, Hagop M. Kantarjian, and Srdan Verstovsek
Blood 2008; 112: 1628-1637.
[Abstract]
[Full text]
[PDF]
A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome
- Stefan Faderl, Farhad Ravandi, Xuelin Huang, Guillermo Garcia-Manero, Alessandra Ferrajoli, Zeev Estrov, Gautam Borthakur, Srdan Verstovsek, Deborah A. Thomas, Monica Kwari, and Hagop M. Kantarjian
Blood 2008; 112: 1638-1645.
[Abstract]
[Full text]
[PDF]
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
- Wendy Stock, Mei La, Ben Sanford, Clara D. Bloomfield, James W. Vardiman, Paul Gaynon, Richard A. Larson, and James Nachman
Blood 2008; 112: 1646-1654.
[Abstract]
[Full text]
[PDF]
Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation
- Karl M. Hoffmann, Andrea Moser, Peter Lohse, Andreas Winkler, Barbara Binder, Petra Sovinz, Herwig Lackner, Wolfgang Schwinger, Martin Benesch, and Christian Urban
Blood 2008; 112: 1655-1657.
[Abstract]
[Full text]
[PDF]
CNS Hodgkin lymphoma
- Elizabeth R Gerstner, Lauren E Abrey, David Schiff, Andrés J. M Ferreri, Andrew Lister, Silvia Montoto, Richard Tsang, Eckhard Thiel, Francesc Graus, Dirk Behringer, Gerald Illerhaus, Susan Weaver, Patrick Wen, Alfredo Voloschin, Nancy Lee Harris, and Tracy T Batchelor
Blood 2008; 112: 1658-1661.
[Abstract]
[Full text]
[PDF]
Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia
- Laura Z. Rassenti, Sonia Jain, Michael J. Keating, William G. Wierda, Michael R. Grever, John C. Byrd, Neil E. Kay, Jennifer R. Brown, John G. Gribben, Donna S. Neuberg, Feng He, Andrew W. Greaves, Kanti R. Rai, and Thomas J. Kipps
Blood 2008; 112: 1923-1930.
[Abstract]
[Full text]
[PDF]
Primary cystic lung light chain deposition disease: a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor
- Magali Colombat, Hervé Mal, Christiane Copie-Bergman, Jacques Diebold, Diane Damotte, Patrice Callard, Michel Fournier, Jean-Pierre Farcet, Marc Stern, and Marie-Hélène Delfau-Larue
Blood 2008; 112: 2004-2012.
[Abstract]
[Full text]
[PDF]
Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population
- Sumithira Vasu, Susan F. Leitman, John F. Tisdale, Matthew M. Hsieh, Richard W. Childs, A. John Barrett, Daniel H. Fowler, Michael R. Bishop, Elizabeth M. Kang, Harry L. Malech, Cynthia E. Dunbar, Hanh M. Khuu, Robert Wesley, Yu Y. Yau, and Charles D. Bolan
Blood 2008; 112: 2092-2100.
[Abstract]
[Full text]
[PDF]
|
|
